428872-06-4 Usage
Description
MC 1293 is a chalcogenide chemical compound, characterized by its white crystalline solid appearance and a molecular formula of Cu2Hg3Te4. With a molecular weight of 1063.11 g/mol, this compound is celebrated for its semiconducting properties, high thermal stability, and resistance to oxidation. These attributes render MC 1293 a promising candidate for a variety of applications, particularly in the electronics and thermoelectric materials industries.
Usage:
Used in Electronic Devices Industry:
MC 1293 is used as a semiconductor material for its ability to facilitate the production of electronic devices and sensors. Its semiconducting properties are crucial in the development of these technologies, enhancing their performance and reliability.
Used in High-Temperature Environments:
In environments where high temperatures are prevalent, MC 1293 is utilized for its exceptional thermal stability and resistance to oxidation. These characteristics make it an ideal component in applications where conventional materials may degrade or fail.
Used in Thermoelectric Materials:
MC 1293 is also used as a thermoelectric material due to its unique electrical and thermal properties. This application takes advantage of the compound's ability to convert thermal energy into electrical energy, making it a valuable asset in energy harvesting and temperature regulation technologies.
Check Digit Verification of cas no
The CAS Registry Mumber 428872-06-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,2,8,8,7 and 2 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 428872-06:
(8*4)+(7*2)+(6*8)+(5*8)+(4*7)+(3*2)+(2*0)+(1*6)=174
174 % 10 = 4
So 428872-06-4 is a valid CAS Registry Number.
428872-06-4Relevant articles and documents
OCULAR HYPOTENSIVE AGENT COMPRISING COMPOUND CAPABLE OF INHIBITING HISTONE DEACETYLASE AS ACTIVE INGREDIENT
-
, (2009/12/28)
An object of the present invention is to find a novel pharmacological effect of a compound having an HDAC inhibitory effect. The compound having an HDAC inhibitory effect of the invention has an excellent effect of cell morphological change on trabecular meshwork cells and/or effect of intraocular pressure reduction, and is therefore useful as a preventive and/or therapeutic agent for a disease considered to be associated with aqueous humor circulation and/or intraocular pressure, particularly as a preventive and/or therapeutic agent for glaucoma or ocular hypertension.
3-(4-Aroyl-1H-pyrrol-2-yl)-N-hydroxy-2-propenamides, a new class of synthetic histone deacetylase inhibitors
Massa,Mai,Sbardella,Esposito,Ragno,Loidl,Brosch
, p. 2069 - 2072 (2007/10/03)
Novel 3-(4-aroyl-2-pyrrolyl)-N-hydroxy-2-propenamides are disclosed as a new class of histone deacetylase (HDAC) inhibitors. Three-dimensional structure-based drug design and conformational analyses into the histone deacetylase-like protein (HDLP) catalyt
